Pacific Biosciences of California, Inc. v. Personal Genomics Taiwan, Inc.
Docket No. 2022-1410, -1554 (IPR2020-01163, -01200 (https://cafc.uscourts.gov/opinions-orders/22-1410.OPINION.1-9-2024_2250463.pdf)
PROST, TARANTO, HUGHES
January 9, 2024
Brief Summary: Board IPR claim construction of “single biomolecule” as one in the context of the disputed patent and prior art determinations affirmed.
Summary: PacBio filed two IPR petitions regarding PGI’s US 7,767,441 directed to “an ‘apparatus for identifying a single biomolecule’ as well as methods of using or making that apparatus”. In one IPR, the USPTO rejected PacBio’s challenge but agreed with PacBio in the other. Both parties appealed, focused on “the Board’s construction
Continue Reading Board IPR construction of “single biomolecule” as one and prior art determinations affirmed
